Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 4
1987 1
1988 1
1989 3
1990 1
1991 2
1992 1
1993 2
1994 3
1997 1
1998 1
1999 1
2001 2
2002 1
2003 1
2004 3
2006 2
2007 2
2009 1
2010 2
2011 2
2012 4
2013 3
2014 4
2015 5
2017 4
2018 2
2019 3
2020 4
2021 7
2022 2
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
Broncho-Vaxom in pediatric recurrent respiratory tract infections: A systematic review and meta-analysis.
Yin J, Xu B, Zeng X, Shen K. Yin J, et al. Int Immunopharmacol. 2018 Jan;54:198-209. doi: 10.1016/j.intimp.2017.10.032. Epub 2017 Nov 16. Int Immunopharmacol. 2018. PMID: 29154122 Review.
OBJECTIVES: Assess the efficacy and safety of Broncho-Vaxom in pediatric recurrent respiratory tract infections (RRTIs). ...CONCLUSION: Broncho-Vaxom shows a good efficacy for pediatric RRTIs on the basis of routine therapy (e.g. anti-infection and ant …
OBJECTIVES: Assess the efficacy and safety of Broncho-Vaxom in pediatric recurrent respiratory tract infections (RRTIs). ...CO …
Broncho-vaxom alleviates persistent allergic rhinitis in patients by improving Th1/Th2 cytokine balance of nasal mucosa.
Meng Q, Li P, Li Y, Chen J, Wang L, He L, Xie J, Gao X. Meng Q, et al. Rhinology. 2019 Dec 1;57(6):451-459. doi: 10.4193/Rhin19.161. Rhinology. 2019. PMID: 31403136 Clinical Trial.
BACKGROUND: Probiotics are mainly distributed in the mucosal system and have the ability to enhance mucosal barrier function and regulate immune responses. Broncho-Vaxom (BV), as a probiotic, has been applied to patients suffering from respiratory tract infections, …
BACKGROUND: Probiotics are mainly distributed in the mucosal system and have the ability to enhance mucosal barrier function and regulate im …
Broncho-Vaxom in children with rhinosinusitis: a double-blind clinical trial.
Zagar S, Löfler-Badzek D. Zagar S, et al. ORL J Otorhinolaryngol Relat Spec. 1988;50(6):397-404. doi: 10.1159/000276020. ORL J Otorhinolaryngol Relat Spec. 1988. PMID: 3068610 Clinical Trial.
Fifty-one children aged 4-12 years, presenting with an acute epidose of chronic rhinosinusitis, were treated for 6 months with either Broncho-Vaxom (BV; marketed in Yugoslavia under the trade mark of Broncho-Munal) or placebo under double-blind randomized conditions …
Fifty-one children aged 4-12 years, presenting with an acute epidose of chronic rhinosinusitis, were treated for 6 months with either Bro
Clinical efficacy of Broncho-Vaxom in adult patients with chronic purulent sinusitis--a multi-centric, placebo-controlled, double-blind study.
Heintz B, Schlenter WW, Kirsten R, Nelson K. Heintz B, et al. Int J Clin Pharmacol Ther Toxicol. 1989 Nov;27(11):530-4. Int J Clin Pharmacol Ther Toxicol. 1989. PMID: 2693373 Clinical Trial.
Broncho-Vaxom or placebo was administered to 284 patients presenting with chronic purulent sinusitis within the bounds of a multicentric, randomized double-blind study. ...The score was 1.55 in the first month of Broncho-Vaxom treatment compared to 1.8
Broncho-Vaxom or placebo was administered to 284 patients presenting with chronic purulent sinusitis within the bounds of a mu
Prevention of infection in immunosuppressive patients with autoimmune nephrosis by using an immunostimulating bacterial lysate Broncho-vaxom.
Zhang M, Luan H, Zhang Q, Wang L, Lv YM, He F, Chen Y, Zeng HB, Yao Y, Liu Q. Zhang M, et al. Hum Vaccin Immunother. 2012 Dec 1;8(12):1802-7. doi: 10.4161/hv.21874. Epub 2012 Aug 24. Hum Vaccin Immunother. 2012. PMID: 22922768 Free PMC article. Clinical Trial.
The present trial was to investigate the efficacy and safety of Broncho-Vaxom on preventing infection in immunosuppressive patients with autoimmune nephrosis. ...CONCLUSION: Broncho-Vaxom might be a good choice for preventing the respiratory infection …
The present trial was to investigate the efficacy and safety of Broncho-Vaxom on preventing infection in immunosuppressive pat …
[Efficacy of the immunostimulant Broncho-Vaxom].
Ahrens J, Wiedenbach M. Ahrens J, et al. Schweiz Med Wochenschr. 1984 Jun 23;114(25):932-4. Schweiz Med Wochenschr. 1984. PMID: 6379870 Clinical Trial. German.
Investigators and patients agreed that Broncho-Vaxom exerts a significantly greater protective effect than placebo. Reports of side effects were more frequent with placebo as compared to Broncho-Vaxom....
Investigators and patients agreed that Broncho-Vaxom exerts a significantly greater protective effect than placebo. Reports of …
OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review.
Schaad UB. Schaad UB. World J Pediatr. 2010 Feb;6(1):5-12. doi: 10.1007/s12519-010-0001-x. Epub 2010 Feb 9. World J Pediatr. 2010. PMID: 20143206 Review.
BACKGROUND: This study was conducted to assess the efficacy of OM-85 BV (Broncho-Vaxom) in the prevention of pediatric recurrent respiratory tract infections (RTIs). ...
BACKGROUND: This study was conducted to assess the efficacy of OM-85 BV (Broncho-Vaxom) in the prevention of pediatric recurre …
Effect of immunostimulation with bacterial lysate on the clinical course of allergic rhinitis and the level of γδT, iNKT and cytotoxic T cells in children sensitized to grass pollen allergens: A randomized controlled trial.
Janeczek K, Kowalska W, Zarobkiewicz M, Suszczyk D, Mikołajczyk M, Markut-Miotła E, Morawska-Michalska I, Bakiera A, Tomczak A, Kaczyńska A, Emeryk A, Roliński J, Piotrowska-Weryszko K. Janeczek K, et al. Front Immunol. 2023 Jan 17;14:1073788. doi: 10.3389/fimmu.2023.1073788. eCollection 2023. Front Immunol. 2023. PMID: 36733480 Free PMC article. Clinical Trial.
[Effect of Broncho-Vaxom on serum IgE and IgG levels in patients with bronchial asthma and chronic obstructive lung disease. A placebo-controlled double-blind study].
Weiss S, Fux T. Weiss S, et al. Schweiz Med Wochenschr. 1987 Sep 26;117(39):1514-8. Schweiz Med Wochenschr. 1987. PMID: 3672087 Clinical Trial. German.
Simultaneously the mean IgG level increased slightly in the atopic patients under Broncho-Vaxom and remained stable in the patients under placebo (p less than 0.10). ...Considering the small number of patients in each group, and the clear tendency towards a diminuti …
Simultaneously the mean IgG level increased slightly in the atopic patients under Broncho-Vaxom and remained stable in the pat …
69 results